
In weight loss battle, Novo and Lilly face growing offensive from licensed copies
By Andrew Silver SHANGHAI (Reuters) – As Novo Nordisk and Eli Lilly expand sales of their popular di...
20th December, 2024

By Andrew Silver SHANGHAI (Reuters) – As Novo Nordisk and Eli Lilly expand sales of their popular di...
20th December, 2024

By Richa Naidu LONDON (Reuters) – Nestle is launching protein shots in the United States which it sa...
18th December, 2024

By Sruthi Shankar (Reuters) -European shares fell to two-week lows on Tuesday, led by energy and hea...
17th December, 2024

By Deena Beasley (Reuters) – Powerful weight-loss drugs are expanding use of U.S. health care as pat...
16th December, 2024

By Michael Erman NEW YORK (Reuters) -Brian Thompson, the CEO of UnitedHealth’s insurance unit, was f...
6th December, 2024

By Dhwani Pandya MUMBAI (Reuters) – Sweden’s EQT has invested more than its targeted $5 billion in I...
5th December, 2024

By Maggie Fick LONDON (Reuters) – Britain’s drugs cost-effectiveness watchdog NICE said on Thursday...
5th December, 2024

By David Milliken LONDON (Reuters) – British employees whose health deteriorates are four times more...
5th December, 2024

LONDON (Reuters) – Britain’s health security agency (UKHSA) said on Friday another case of the new m...
29th November, 2024

By Ludwig Burger and Stine Jacobsen (Reuters) – Shares of weight-loss drugmakers Novo Nordisk and El...
26th November, 2024

By Catarina Demony LONDON (Reuters) – British lawmakers will on Tuesday debate and vote on plans to...
26th November, 2024

By Patrick Wingrove (Reuters) – More than 200,000 prescriptions for copies of Novo Nordisk’s weight-...
25th November, 2024